Learning how to raise capital for your business idea is often difficult for many otherwise very capable would be entrepreneurs. Raising finance, be it from a bank, a venture capital firm or a business angel, has a lot to do with being able to sell your business idea, and less about how good that idea actually is. The best business idea can get nowhere if you cannot convince your prospective investors of its potential as an investment and your ability as a business owner of making it a success. You should keep the following key points in mind when trying to raise capital for your new business idea.Prepare a business planWriting a business plan is often a lot of work and distracts you from doing what you want to do, which is running your business. But you won’t get any funding without a solid written business plan. Telling an investor or your bank contact that they should give you money because you had a great idea is just not going to cut it. A business plan will explain exactly what you plan on doing with that money, why you need it and real numbers proving your business idea potential. Among other things, you’ll need to be able to prove that you know your audience and the size of the market you plan on targeting, your marketing plans, your expected cashflow for the first few years and how will you deal with risks such as another competitor entering the market. If you are unsure about how to write a good business plan you can also hire a consultant to help you prepare it, but make sure you know exactly what’s in it, since the consultant won’t be with you when talking to the potential investors.Practice your pitchLooking for investment is like selling your business idea to somebody who knows a lot about what makes a good, profitable business. While a good business plan is the basis for your pitch, you will still need to deliver it the right way. It’s worth investigating your potential investors, and adapting your pitch to that information. For example, a bank is often conservative and would be more interested in you showcasing how your business idea is a safe bet and has a solid base, without extravagant expenses or high risk taking. However, an investor with an existing portfolio of cutting edge technological business may be more interested in listening to how your business is highly innovative and will use the money to create the next big thing online. Do not go into any meeting with your investors without researching all you can about them and their style, since they will have no doubt researched you to see if you, as a person and a businessman, are likely to succeed.Plan for threats and weaknessesRemember when at job interviews people asked you to name your weak points? Your investors are going to do exactly the same about your business idea. While it’s clear that you wouldn’t be asking for investment if you didn’t believe your business idea has a high potential for success, you should also be aware of what things could make it fail, and be able to plan for it. Do not say “Nothing can go wrong, I have everything covered” because at best you’ll get a reality check from the investors about the many things you had not considered, before politely being shown the door. Being secure of yourself is great, but realism is highly appreciated in business.Know your USPWhat makes your business idea unique, and so makes people choose you over anybody else to buy from? Your unique selling point, or USP, will be key to your marketing strategy since it’s the reason why people will buy from you. A generic business with no unique selling point is not likely to make venture investors interested, because if anybody can do it, it’s probably not going to be very profitable. Investors want a high return on investment, and that means that your business should grow and not just be good enough for you to make a living. On the other hand, a bank may be less demanding with your uniqueness, as long as you are using a proven business model on a niche that has room for new players, but a bank knows that they’ll get their payment through your loan interest so they are satisfied with you just breaking even and paying your loan.Show that you the right person to lead your businessThis is another challenging issue when trying to get finance, and a question that few investors will ask you directly so you need to show it by your actions and your sales pitch. Some people are great at having ideas, but are very bad at making those ideas into a real business and managing the day to day of said business. As a business owner, you’ll need many skills that aren’t directly related to your business core idea. Even if you are technically the best developer in the world, and the person who can best implement your idea, you may not be the right person to actually manage it and many investors will notice that unfavourably. Make sure you come across as a savvy businessperson, and not just a great inventor or a proficient salesman.
S&P 500 Biotech Giant Vertex Leads 5 Stocks Showing Strength
Your stocks to watch for the week ahead are Cheniere Energy (LNG), S&P 500 biotech giant Vertex Pharmaceuticals (VRTX), Cardinal Health (CAH), Steel Dynamics (STLD) and Genuine Parts (GPC).
X
While the market remains in correction, with analysts and investors wary of an economic downturn, these five stocks are worth adding to watchlists. S&P 500 medical giants Vertex and Cardinal Health have been holding up, as health-care related plays tend to do well in down markets.
Steel Dynamics and Genuine Parts are both coming off strong earnings as both the steel and auto parts industries report optimistic outlooks. Meanwhile, Cheniere Energy saw sales boom in the second quarter as demand in Europe for natural gas continues to grow.
Major indexes have been making rally attempts with the Dow Jones and S&P 500 testing weekly support on Friday. With market uncertainty, investors should be ready for follow-through day breakouts and keep an eye on these stocks.
Cheniere Energy, Cardinal Health and VRTX stock are all on IBD Leaderboard.
Cheniere Energy Stock
LNG shares rose 1.1% to 175.79 during Friday’s market trading. On the week, the stock advanced 3.1%, not from highs, bouncing from its 21-day and 10-week lines earlier in the week.
Cheniere Energy has been consolidating since mid-September, but needs another week to forge a proper base, with a potential 182.72 buy point formed on Aug. 10.
Houston-based Cheniere Energy was IBD Stock Of The Day on Thursday, as the largest U.S. producer of liquefied natural gas eyes strong demand in Europe.
Even though natural gas prices are plunging in the U.S. and Europe, investors still see strong LNG demand for Cheniere and others.
The U.K. government confirmed last week that it is in talks for an LNG purchase agreement with a number of companies, including Cheniere.
In the first half of 2021, less than 40% of Cheniere’s cargoes of LNG landed in Europe. That jumped to more than 70% through this year’s second quarter, even as the company ramped up new export capacity. The urgency of Europe’s natural gas shortage only intensified last month. That is when an explosion disabled the Nord Stream 1 pipeline from Russia that had once supplied 40% of the European Union’s natural gas.
In Q2, sales increased 165% to $8 billion and LNG earned $2.90 per share, up from a net loss of $1.30 per share in Q2 2021. The company will report Q3 earnings Nov. 3, with investors seeing booming profits for the next few quarters.
Cheniere Energy has a Composite Rating of 84. It has a 98 Relative Strength Rating, an exclusive IBD Stock Checkup gauge for share price movement with a 1 to 99 score. The rating shows how a stock’s performance over the last 52 weeks holds up against all the other stocks in IBD’s database. The EPS rating is 41.
Vertex Stock
VRTX stock jumped 3.4% to 300 on Friday, rebounding from a test of its 50-day moving average. Shares climbed 2.2% for the week. Vertex stock has formed a tight flat base with an official buy point of 306.05, according to MarketSmith analysis.
The stock has remained consistent over recent weeks, while the relative strength line has trended higher. The RS line tracks a stock’s performance vs. the S&P 500 index.
Vertex Q3 earnings are on due Oct. 27. Analysts see EPS edging up 1% to $3.61 per share with sales increasing 16% to $2.2 billion, according to FactSet.
The Boston-based global biotech company dominates the cystic fibrosis treatment market. Vertex also has other products in late-stage clinical development that target sickle cell disease, Type 1 diabetes and certain genetically caused kidney diseases. That includes a gene-editing partnership with Crispr Therapeutics (CRSP).
In early August, Vertex reported better-than-expected second-quarter results and raised full-year sales targets.
S&P 500 stock Vertex ranks second in the Medical-Biomed/Biotech industry group. VRTX has a 99 Composite Rating. Its Relative Strength Rating is 94 and its EPS Rating is 99.
CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures?
Cardinal Health Stock
CAH stock advanced 3.2% to 73.03 Friday, clearing a 71.22 buy point from a shallow cup-with-handle base and hitting a record high. But volume was light on the breakout. CAH stock leapt 7.3% for the week.
Cardinal Health stock’s relative strength line has also been trending up for months.
The cup-with-handle base is part of a base-on-base pattern, forming just above a cup base cleared on Aug. 11.
Cardinal Health, based in Dublin, Ohio, offers a wide assortment of health care services and medical supplies to hospitals, labs, pharmacies and long-term care facilities. The company reports that it serves around 90% of hospitals and 60,000 pharmacies in the U.S.
S&P 500 stock Cardinal Health will report Q1 2023 earnings on Nov. 4. Analysts forecast earnings falling 26% to 96 cents per share. Sales are expected to increase 10% to $48.3 billion, according to FactSet.
Cardinal Health stock ranks first in the Medical-Wholesale Drug/Supplies industry group, ahead of McKesson (MCK), which is also showing positive action. CAH stock has a 94 Composite Rating out of 99. It has a 97 Relative Strength Rating and an EPS rating of 73.
Steel Dynamics Stock
STLD shares shot up 8.5% to 92.92 on Friday and soared 19% on the week, coming off a Steel Dynamics earnings beat Wednesday night.
Shares blasted above an 88.72 consolidation buy point Friday after clearing a trendline Thursday. STLD stock is 17% above its 50-day line, definitely extended from that key average.
Steel Dynamics’ latest consolidation could be seen as part of a larger base going back six months.
Steel Dynamics topped Q3 earnings views with EPS rising 10% to $5.46 while revenue grew 11% to $5.65 billion. The steel producer’s outlook is optimistic despite weaker flat rolled steel pricing. STLD reports its order activity and backlogs remain solid.
The Fort Wayne, Indiana-based company is among the largest producers of carbon steel products in the U.S. It engages in metal recycling operations along with steel fabrication and produces myriad steel products.
How Millett Grew Steel Dynamics From A Three Employee Business
STLD stock ranks first in the Steel-Producers industry group. STLD stock has a 96 Composite Rating out of 99. It has a 90 Relative Strength Rating, an exclusive IBD Stock Checkup gauge for share-price movement that tops at 99. The rating shows how a stock’s performance over the last 52 weeks holds up against all the other stocks in IBD’s database. The EPS rating is 98.
Genuine Parts Stock
GPC stock gained 2.8% to 162.35 Friday after the company topped earnings views with its Q3 results on Thursday. For the week GPC advanced 5.1% as the stock held its 50-day line and is in a flat base.
GPC has an official 165.09 flat-base buy point after a three-week rally, according to MarketSmith analysis.
The relative strength line for Genuine Parts stock has rallied sharply to highs over the past several months.
On Thursday, the Atlanta-based auto parts company raised its full-year guidance on growth across its automotive and industrial sales.
Genuine Parts earnings per share advanced 19% to $2.23 and revenue grew 18% to $5.675 billion in Q3. GPC’s full-year guidance is now calling for EPS of $8.05-$8.15, up from $7.80-$7.95. The company now forecasts revenue growth of 15%-16%, up from the earlier 12%-14%.
During the Covid pandemic, supply chain constraints caused a major upheaval in the auto industry, sending prices for new and used cars to record levels. This has made consumers more likely to hang on to their existing vehicles for longer, driving mileage higher and boosting demand for auto replacement parts.
Fellow auto stocks O’Reilly Auto Parts (ORLY) and AutoZone (AZO) have also rallied near buy points amid the struggling market. O’Reilly reports on Oct. 26.
IBD ranks Genuine Parts first in the Retail/Wholesale-Auto Parts industry group. GPC stock has a 96 Composite Rating. Its Relative Strength Rating is 94 and it has an EPS Rating of 89.
Why Is Organic Antioxidant Skin Care The Very Best For Your Skin?
These might at first glance sound like easy questions to answer.1. Are all skin care products out in the market place safe?
2. Can you develop skin conditions just from using certain skin care products?
3; Can skin care products actually cause serious harm to your health?
4. Are there skin care products that are effective and also good for your health and cause no harm to your skin?Question number one is a resounding no! There are many skin care product lines that are widely sold in the market place that are not safe. Many of these skin care products contain caustic chemicals, preservatives and many other additives that can cause not only skin reactions but can also lead to serious conditions both on your skin and for your overall health.The answer to question number two is yes. Many people develop skin conditions from the products they are using and don’t even know that the products are the source. They keep using the products they are familiar with and use makeup to cover the problems. When a skin care product has a variety of synthetic chemicals in it the potential for negative reactions to the skin are widely different for different people.Question number three’s answer is also yes. Long term use of chemical ingredient skin care products can cause many forms of long term health issues. Like cancer, auto immune disease. There are many types of illnesses that are related to the absorption of toxic compounds through the skin. It’s bad enough that we all absorb toxic compounds just being exposed to the environment, we live in a very toxic world these days. Then to also add more toxic chemicals willingly through the skin care products you use is insult to injury.Question number four is answered yes. There are definitely skin care products available that are not only very effective but also good for your health and for your skin.
This what the rest of this article is about, the positive message that you can take great care of your skin, stay looking younger, heal and prevent skin conditions and prevent serious health problems that can start through your skin.The concept of organic skin care has gained a lot of attention. The idea that what you put on your skin should be pure, chemical free and have no synthetic ingredients makes perfect sense. If you believe it’s better to eat organic food, as opposed to food grown with pesticides, herbicides and other chemicals, or foods processed with preservatives, additives and other unnatural food compounds, then the same should go for skin care.Of coarse you should be conscious and concerned about the food you eat and it’s effect on your health, you should also be conscious about what you put on your skin.Your skin being your bodies largest organ is the filter and the protector for your body from all the toxicity you are exposed to in the modern world. If you have healthy well treated skin that has been fed lots of antioxidants and your are internally also healthy with a strong immune system, you can fight off all the free radicals that attack you through your skin and can potentially cause serious damage to your health.Antioxidants are if not the most important compounds, they rank right at the top of the organic compounds we all need in our bodies and on our skin. We have to add them daily and keep the absorption of antioxidants at a consistently high level. It is sad to say but we do live in a very polluted world and much of this toxicity in deliberately added in the quest for profitable products. Companies get their products approved without the longer term health studies that should be completed so the consumer can be assured the products are safe.The only real clear way to know for sure whether a specific skin care product has no harmful side effects, is to only use organic products that have zero synthetic additives, chemicals or other ingredients that are not from the natural world. Of coarse there are compounds in the natural world that are toxic, and ingredients in organic products that can effect different people in different ways, so as with any product or food, read the labels and know what you are eating or putting on your skin. If the company is a reputable company with a positive track record and their skin care products are all organic it is a good bet they will do you no harm.